Approval · Notice of Compliance 2900 · 2003
AMATINE: Notice of Compliance 2900
Issued February 28, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2900
- Date
- February 28, 2003
- Company
- Shire Canada IncLaval, QC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional strength
- Therapeutic class
- Vasopressor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMATINE | 02247148 | — |
Medicinal ingredients
- MIDODRINE HCL 10 MG per TAB